Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

159.19
Delayed Data
As of Jun 22
 +2.62 / +1.67%
Today’s Change
125.50
Today|||52-Week Range
178.25
+6.23%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues580.4M1.0B1.7B2.5B
 
 
 
 
 
Cost of Goods Sold29.4M62.2M149.1M213.7M
 
 
 
 
 
Depreciation And Amortization63.3M62.3M61.4M61.4M
 
 
 
 
 
 
Operating ExpensesGross Income487.8M907.8M1.5B2.2B
 
 
 
 
 
General Expenses1.1B1.4B1.5B1.8B
 
 
 
 
 
Research And Development855.5M995.9M1.0B1.3B
 
 
 
 
 
Total Operating Expenses1.2B1.5B1.7B2.1B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-641.5M-464.7M11.2M397.9M
 
 
 
 
 
Extraordinary Charge-79.9M-2.2M-1.3M-288.8M
 
 
 
 
 
Interest Expense On Debt72.9M84.2M81.4M57.6M
 
 
 
 
 
Other Expenses59.4M-6.7M4.1M-67.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-734.9M-557.8M-67.4M-15.7M
 
 
 
 
 
Income Taxes-7.0M-30.4M-16.7M-107.3M
 
 
 
 
 
Minority Interest-4.2M-31.8M-28.0M-171.8M
 
 
 
 
 
Discontinued Operations-912.0K0.000.000.00
 
 
Net Income-738.6M-556.3M-112.1M263.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS235.3M241.3M244.7M248.9M
 
 
 
 
 
Shares To Calculate EPS Diluted235.3M241.3M244.7M253.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.14-$2.31-$0.46$1.04
 
 
 
 
 
EPS Diluted-$3.14-$2.31-$0.46$1.04